Business Wire

Teledyne FLIR Defense Launches Black Recon™ Autonomous Micro-Drone

15.6.2026 06:05:00 CEST | Business Wire | Press Release

Share

Teledyne FLIR Defense, part of Teledyne Technologies Incorporated (NYSE: TDY), today announced at Eurosatory the market launch of Black Recon™, an autonomously launched micro-drone system that delivers continuous, untethered reconnaissance from military vehicles and fixed installations.

This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260614388428/en/

Teledyne FLIR Defense announced at Eurosatory the market launch of Black Recon™, an autonomously launched micro-drone that delivers continuous, untethered reconnaissance from military vehicles and fixed installations. Black Recon allows crews to launch, operate, recover, and recharge up to three UAS without leaving their platform, reducing operator risk.

Designed for vehicle integration, Black Recon allows crews to launch, operate, recover, and recharge up to three unmanned aerial systems without leaving their platform, reducing risk and accelerating decision-making.

“Black Recon represents a major step forward in integrated reconnaissance for ground forces,” said Dr. JihFen Lei, President of Teledyne Defense and Aerospace Group and Senior Vice President of Teledyne Technologies. “By bringing autonomous launch, recovery, and recharging directly to the vehicle, we give operators persistent situational awareness, faster access to actionable intelligence, and greater protection in high-tempo missions.”

Key system capabilities include:

  • Autonomous launch, recovery, and recharge from the safety of the platform
  • Three-UAV rotation for near-continuous overwatch
  • Thermal and visible payloads for real-time imagery and targeting data
  • Global Navigation Satellite System (GNSS)-denied operation enabled by advanced sensors and visual navigation
  • Radio-silent missions using Visual Inertial Navigation, without reliance on RF links
  • Extended range and radio coverage through onboard relay capability
  • Compatible operation with Black Hornet 4 nano-drone
  • Optional 100-gram mission modules for future lethality, sensor, and CBRN payloads

A Fully Integrated, Autonomous Reconnaissance Capability
Black Recon is a compact, hardened system for vehicles or fixed installations that deploys up to three micro-UAVs in rotation for persistent surveillance. Each UAV launches autonomously, performs reconnaissance, surveillance, and target acquisition (RSTA) missions, then returns to the launcher for capture, docking, and recharging. The result is uninterrupted ISR coverage day or night while keeping personnel protected inside the platform.

Designed for ‘Dynamic Reusability’ in High-Tempo Operations
Unlike legacy drones adapted for dismounted use, Black Recon is engineered for mounted platforms, enabling immediate ISR deployment without external aviation support.

With 50- to 60-minute flight times and speeds up to 25 m/s per UAV, Black Recon extends surveillance beyond traditional engagement ranges, supporting continuous target tracking, rapid threat detection, and shortening the decision cycle across all mission profiles.

Low SWaP, High Performance
Weighing less than 450 grams, each Black Recon UAV combines low size, weight, and power with advanced sensing derived from Teledyne FLIR Defense’s proven nano-UAS portfolio. Autonomous navigation allows missions to continue in GPS-jammed or spoofed environments.

Expanding Beyond the Battlefield
Originally developed for military use, Black Recon’s flexible architecture also supports public safety and security applications, including:

  • Remote first responder deployments for law enforcement
  • Border and perimeter security
  • Critical infrastructure monitoring
  • Maritime and riverine patrols

Its rugged, network-enabled design supports both fixed and mobile deployment, providing rapid situational awareness in remote and hard-to-reach environments.

Future-Ready, Modular by Design
Black Recon’s open mission-module architecture is built to evolve with operational requirements. Planned future modules include lethality payloads and CBRN detection sensors, expanding the system from persistent reconnaissance to hazard detection and active engagement.

Black Recon is available for order now, with deliveries expected to begin in 2027.

Visit Teledyne FLIR Defense at Eurosatory, Hall 5A, Stand A129, to see the Black Recon in person or learn more online.

About Teledyne FLIR Defense

Teledyne FLIR Defense has been providing advanced, mission-critical technology and systems for more than 45 years. Our products are on the frontlines of the world’s most pressing military, security and public safety challenges. As a global leader in thermal imaging, we design and build sophisticated surveillance sensors for air, land and maritime use. We develop the most rugged, trusted unmanned air and ground platforms, as well as intelligent sensing devices used to detect chemicals, biological agents, radiation and explosives. At Teledyne FLIR Defense we bring together this expertise to deliver solutions that enable critical decisions and keep our world safe – from any threat, anywhere. To learn more, visit us online or follow @flir_defense.

About Teledyne Technologies

Teledyne Technologies is a leading provider of sophisticated digital imaging products and software, instrumentation, aerospace and defense electronics, and engineered systems. Teledyne's operations are primarily located in the United States, the United Kingdom, Canada, and Western and Northern Europe. For more information, visit Teledyne's website at www.teledyne.com.

View source version on businesswire.com: https://www.businesswire.com/news/home/20260614388428/en/

Contacts

Media Contacts:
Joe Ailinger, Jr.
Teledyne Defense & Aerospace
Email: joe.ailinger@teledyne.com

Tabitha Blankenbiller
Teledyne Defense & Aerospace
Email: Tabitha.blankenbiller@teledyne.com

(c) 2024 Business Wire, Inc., All rights reserved.

Business Wire, a Berkshire Hathaway company, is the global leader in multiplatform press release distribution.

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

LTM Launches BlueVerse™ for iRun to Outcreate Managed Services in the Agentic AI Era15.6.2026 08:10:00 CEST | Press Release

LTM, the Business Creativity partner to the world’s largest enterprises, today announced the launch of BlueVerse™ for iRun, an AI-native managed services model designed to transform traditional IT operations into a resilient, intelligent, and outcome-driven operating model. As enterprise environments grow more complex—spanning hybrid cloud, SaaS, and AI-driven ecosystems—traditional managed services models are increasingly constrained by siloed teams, static processes, and effort-led scaling. BlueVerse for iRun addresses this shift by moving beyond headcount-based delivery to a platform-led approach powered by agentic AI, knowledge convergence, and process-as-code. Built on the BlueVerse ecosystem, iRun creates a unified intelligence layer that brings together enterprise data, telemetry, workflows, and operational context—enabling AI to reason across systems, identify root causes, and execute actions within governed guardrails. iRun combines AI agents and human expertise to shift opera

Azafaros to Present at BIO International Convention 202615.6.2026 07:00:00 CEST | Press Release

Azafaros, a private company building a portfolio to become a leader in lysosomal storage disorders (LSDs), focused on addressing neurological symptoms, today announced that it will present at the 2026 BIO International Convention taking place in San Diego, USA, from June 22-25. The company’s presentation is scheduled for Monday, June 22 at 4:30 PM in Theater 4. The presentation will highlight Azafaros’ progress in developing nizubaglustat, its lead investigational compound for the treatment of rare lysosomal storage disorders with neurological involvement, including GM1 and GM2 gangliosidoses (GM1/GM2) and Niemann-Pick type C disease (NPC). Nizubaglustat is currently in two Phase 3 registrational studies (NAVIGATE) treating patients with GM1/GM2 and NPC and expects to report topline data from the studies in 2028. “BIO provides an important opportunity to update our progress as we continue advancing nizubaglustat through late-stage clinical development,” said Stefano Portolano, CEO at A

OM Pharma to Unveil the Largest Multi-Country Real-World Evidence Study on Broncho‑Vaxom® (OM‑85) for RTI Prevention at EAACI 202614.6.2026 10:00:00 CEST | Press Release

OM Pharma will reveal preliminary results from the REACH study at the European Academy of Allergy and Clinical Immunology (EAACI) Congress. REACH is the first and largest multi-country real-world evidence (RWE) study to date evaluating the impact of Broncho-Vaxom® in patients with recurrent respiratory tract infections (RTIs).1,2 The findings offer critical new clinical evidence of the therapy's effectiveness in everyday clinical practice. In a real-world cohort of 15,794 paediatric (aged >1 year), adolescent, adult and elderly patients in China, Italy, and Belgium, Broncho-Vaxom® was associated with reductions in RTI recurrence and healthcare utilisation at 12 and 24 months after treatment initiation, compared with the 12 months prior to starting the therapy.1 “The REACH real-world evidence study shows that Broncho-Vaxom® can significantly reduce infections requiring medical visits across age groups and co-morbidities,” said Anna Thomas, Chief Scientific Officer at OM Pharma. “Recurre

Incyte Announces New Positive Data at EHA 2026 Showed INCA033989 Achieved Rapid, Robust and Sustained Clinical and Molecular Responses and Was Well Tolerated in Patients with Myelofibrosis and Essential Thrombocythemia13.6.2026 17:15:00 CEST | Press Release

Incyte (Nasdaq:INCY) today announced updated clinical data from two Phase 1 studies evaluating the safety, tolerability and efficacy of INCA033989, a first-in-class mutant calreticulin (mutCALR)-targeted monoclonal antibody, in patients with mutCALR-expressing myeloproliferative neoplasms (MPNs). INCA033989 demonstrated rapid, clinically meaningful responses and consistent molecular activity across both myelofibrosis (MF) and essential thrombocythemia (ET), with convergent evidence supporting the potential for disease modification. These findings are being presented in oral and poster presentations at the European Hematology Association (EHA) 2026 Congress in Stockholm, Sweden (Session: Myeloproliferative neoplasms – Clinical, Presentation numbers: S216, PS1983, PF884). “The data presented at EHA 2026 demonstrate clinically meaningful and consistent responses with INCA033989 across both myelofibrosis and essential thrombocythemia,” said Pablo J. Cagnoni, M.D., President of Incyte and G

Results from Incyte’s Pivotal Phase 3 frontMIND Trial of Tafasitamab (Monjuvi ® /Minjuvi ® ) Combination Presented at the 2026 European Hematology Association (EHA) Congress Plenary Showed Prolonged Progression Free Survival13.6.2026 12:00:00 CEST | Press Release

Incyte (Nasdaq:INCY) today announced positive results from the pivotal Phase 3 frontMIND trial evaluating the efficacy and safety of tafasitamab (Monjuvi®/Minjuvi®), a humanized Fc-modified cytolytic CD19-targeting monoclonal antibody, and lenalidomide added to R-CHOP (rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone; Tafa-Len-R-CHOP) versus R-CHOP, the current standard of care, as a first-line treatment for adults with previously untreated diffuse large B-cell lymphoma (DLBCL) or high-grade B-cell lymphoma (HGBL). Eligible patients had an International Prognostic Index (IPI) score of 3-5, or, for patients ≤60 years of age, an age-adjusted IPI (aaIPI) of 2-3. These data are being highlighted in a prestigious Plenary Abstracts Session at the European Hematology Association (EHA) 2026 Congress, being held June 11 - 14, 2026, in Stockholm, Sweden (Abstract # S101. Plenary Abstract Session. June 13, 6:00 - 7:30 a.m. ET [12:00-1:30 p.m. CEST]). frontMIND results were als

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye